Signalebd3fb92

WEBINDEXED

Pharmaceutical Research and Manufacturers of America disclosed $6.2M in Q3 2023 lobbying targeting IRA implementation rules at CMS.

Published:2023-10-20 00:00 UTC

Occurred:2023-07-01 00:00 UTC

Received:2026-07-15 08:00 UTC

Status Score

81%

ITG

87%

IMP

71%

NAR

22%

Analysis Insights

Topics Detected

#Lobbying Disclosures#Drug Pricing

Entities Mentioned

@PhRMA@CMS@Inflation Reduction Act

Technical Details

Analyst Mission

Corporate Lobbying Trackera76754d3...

Source IDN/A

Original URLN/A

Database IDebd3fb92-0d7d-4e49-8bc9-b4f3164e52a2

Raw Data

{
  "id": "ebd3fb92-0d7d-4e49-8bc9-b4f3164e52a2",
  "content": "Pharmaceutical Research and Manufacturers of America disclosed $6.2M in Q3 2023 lobbying targeting IRA implementation rules at CMS.",
  "url": null,
  "source_type": "web",
  "source_id": null,
  "author_id": null,
  "published_at": "2023-10-20T00:00:00.000Z",
  "received_at": "2026-07-15T08:00:26.032Z",
  "status": "indexed",
  "relevance_score": 81,
  "case_id": null,
  "metadata": {
    "topics": [
      "Lobbying Disclosures",
      "Drug Pricing"
    ],
    "mission": "Corporate Lobbying Tracker",
    "mentions": [
      "PhRMA",
      "CMS",
      "Inflation Reduction Act"
    ],
    "mission_id": "a76754d3-444f-44d8-bf31-a548a575182e"
  },
  "credibility_score": 87,
  "actionability_score": 71,
  "emotional_score": 22,
  "occurred_at": "2023-07-01T00:00:00.000Z",
  "case_ids": null
}